Tag: Cipla

Cipla signs licensing deal with Lilly to sell two diabetes drugs in India

businessnewstoday- October 4, 2021 0

Cipla has signed a licensing deal with the Indian subsidiary of US pharma giant Eli Lilly and Company (Lilly) pertaining to the latter’s diabetes treatments ... Read More

Cipla gets FDA approval for generic version of Novartis’ Durezo

businessnewstoday- August 12, 2021 0

Cipla Limited said that it has secured final approval for its abbreviated new drug application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the US Food ... Read More

Cipla, Dr. Reddy’s, and others to collaborate on Molnupiravir Covid trial

businessnewstoday- June 29, 2021 0

Five Indian pharma companies – Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals will join forces to undertake a clinical trial ... Read More

Cipla associate Avenue Therapeutics fails to get FDA approval for IV tramadol

businessnewstoday- June 15, 2021 0

Cipla’s step-down associate firm Avenue Therapeutics has failed to get approval from the US Food and Drug Administration (FDA) for IV tramadol as an alternative ... Read More

Cipla partners with MSD to manufacture and distribute Molnupiravir drug to treat Covid-19

businessnewstoday- April 28, 2021 0

Cipla has entered into a non-exclusive licensing agreement with MSD (called Merck in the US and Canada) for the manufacturing and distribution of Molnupiravir (EIDD-2801/MK-4482), ... Read More

Cipla, Stempeutics Research to launch Stempeucel for critical limb ischemia

pharmanewsdaily- August 23, 2020 0

Cipla announced that its partner Stempeutics Research has secured regulatory approval from the Drug Controller General of India (DCGI) for the launch of Stempeucel, a ... Read More

Cipla gets FDA’s final approval for generic version of Migranal with CGT designation

pharmanewsdaily- May 21, 2020 0

Cipla has secured final approval for its abbreviated new drug application (ANDA) for Dihydroergotamine Mesylate Nasal Spray 4mg/mL from the US Food and Drug Administration ... Read More